Clinical Trial Update: Ticagrelor Versus Prasugrel in Acute Coronary Syndromes After Percutaneous Coronary Intervention [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing ticagrelor and prasugrel in acute coronary syndrome patients after percutaneous coronary intervention has completed; the results are n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Syndrome

Drugs mentioned

• PRASUGREL (prasugrel)
• TICAGRELOR (ticagrelor)

Snippet

Sponsor: University of Patras | Conditions: Coronary Artery Disease, Acute Coronary Syndrome | Phase 3 | Status: COMPLETED